Connor, Clark & Lunn Investment Management Ltd. Lumos Pharma, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$6.58 - $10.09 $394 - $605	-60 Reduced 0.18%	33,367 $315,000
Q3 2021 Nov 12, 2021	BUY	$7.36 - $11.36 $10,959 - $16,915	1,489 Added 4.66%	33,427 $318,000
Q2 2021 Aug 12, 2021	SELL	$9.75 - $13.44 $13,211 - $18,211	-1,355 Reduced 4.07%	31,938 $317,000
Q1 2021 May 13, 2021	BUY	$11.58 - $31.11 $23,646 - $63,526	2,042 Added 6.53%	33,293 $390,000
Q4 2020 Feb 16, 2021	SELL	$13.61 - $35.91 $9,894 - $26,106	-727 Reduced 2.27%	31,251 $1.12 Million
Q3 2020 Nov 12, 2020	SELL	$13.25 - $16.5 $60,327 - $75,124	-4,553 Reduced 12.46%	31,978 $442,000
Q2 2020 Aug 13, 2020	SELL	$7.76 - $16.99 $3,872 - $8,478	-499 Reduced 1.35%	36,531 $602,000
Q1 2020 May 13, 2020	BUY	$0.89 - $8.85 $32,956 - $327,715	37,030 New	37,030 $0

Others Institutions Holding LUMO

# of Institutions

Shares Held

2.2M

Call Options Held

Put Options Held

Private Advisor Group, LLC

745K
Shares

$3.22 Million
0.02% of portfolio
Goldman Sachs Group Inc New York, NY

362K
Shares

$1.57 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

244K
Shares

$1.06 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

214K
Shares

$925,814
0.0% of portfolio
Jefferies Financial Group Inc. New York, NY

121K
Shares

$522,418
0.0% of portfolio

View Full List

About LUMOS PHARMA, INC.

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

More about LUMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account